PRESS RELEASES

September, 2016

EIGHT BIOPHARMACEUTICAL COMPANIES BUILD BETTER RELATIONSHIPS WITH C-SUITE EXECUTIVES

AstraZeneca, Baxter, Boehringer Ingelheim, Johnson & Johnson HCS, Lilly, Merck, Novo Nordisk, and Pfizer—perform well across four cornerstones that drive company relationships with c-suite executives at hospitals and health systems.

September, 2016

HEALTH STRATEGIES GROUP LAUNCHES NEW RESEARCH MARKET ACCESS CUSTOMER RELATIONSHIPS

Health Strategies Group has announced the launch of its new research, Market Access Customer Relationships, focused on benchmarking your team’s performance against competitors on the competencies and attributes that lead to stronger customer relationships.

June, 2016

SIX COMPANIES EFFECTIVELY PARTNER WITH CONTRACTING DECISION MAKERS

AstraZeneca, BI, J&J HCS, Merck, Novartis, and Novo Nordisk achieve high marks in new report

May, 2016

HEALTH STRATEGIES GROUP LAUNCHES NEW RESEARCH BULLETIN BOARD: THE IMPACT OF BIOSIMILAR DRUGS ON MARKET ACCESS

Health Strategies Group has announced the launch of a new turnkey research focused on the impact of biosimilars on market access.

April, 2016

HEALTH STRATEGIES GROUP LAUNCHES NEW SUITE OF SERVICES FOR MARKET ACCESS BRAND MARKETERS

Health Strategies Group has announced the launch of a new suite of services for market access brand marketers that features three new services that organizes content around a client’s business questions – specific to their therapeutic market across multiple customer segments.

Disclaimer

 

Please complete the form to have this document sent to your email.

 

Please complete the form to have this document sent to your email.